Intersect Capital’s Eastman Chemical EMN Stock Holding History

Intersect Capital’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$231K	Sell	2,568 -971	-27%	-$101K	0.07%	291
2022 Q1	$397K	Sell	3,539 -623	-15%	-$73K	0.08%	240
2021 Q4	$503K	Sell	4,162 -38	-0.9%	-$4.22K	0.09%	198
2021 Q3	$423K	Sell	4,200 -987	-19%	-$109K	0.07%	215
2021 Q2	$606K	Buy	5,187 +178	+4%	+$21.4K	0.11%	156
2021 Q1	$552K	Buy	5,009 +562	+13%	+$61K	0.11%	146
2020 Q4	$446K	Buy	4,447 +1,843	+71%	+$171K	0.1%	159
2020 Q3	$203K	Buy	+2,604	New	+$196K	0.05%	224

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Intersect Capital's EMN Position: Q2 2022 in Review

Intersect Capital reduced its Eastman Chemical (EMN) stake by 27% in Q2 2022, selling an estimated $101K and leaving 2,568 shares worth $231K. The position accounts for 0.07% of the portfolio, ranked #291.

Intersect Capital first reported a position in EMN in Q3 2020 and has held it in 8 quarters since. The position peaked at $606K in Q2 2021. 688 funds tracked by Wall St. Rank hold EMN as of Q2 2022.

Intersect Capital held 2,568 shares of Eastman Chemical worth $231K as of Q2 2022.
Intersect Capital sold 971 Eastman Chemical shares in Q2 2022, an estimated $101K.
Eastman Chemical made up 0.07% of Intersect Capital's portfolio in Q2 2022, its #291 holding.
Intersect Capital first reported a position in Eastman Chemical in Q3 2020 and has held it in 8 quarters since.
Intersect Capital's Eastman Chemical position peaked at $606K in Q2 2021.
688 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2022.

Based on Intersect Capital's 13F filing for Q2 2022, filed 2 Sep 2022.